v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation.
about
Regulation of acidification and apoptosis by SHP-1 and Bcl-2Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferationNon-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptorA novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3Apoptosis: molecular regulation of cell deathAntiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis.The carboxyl terminus of v-Abl protein can augment SH2 domain function.Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cellsKinase cascades regulating entry into apoptosis.Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase.Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy.Disrupted signaling in a mutant J2E cell line that shows enhanced viability, but does not proliferate or differentiate, with erythropoietin.Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death.
P2860
Q22010599-D6232A10-BC96-4A4D-8920-E9A26C11B503Q24522820-AD89BCD4-7CAE-4106-8E17-89218AE7CB7DQ28140259-D03FB437-2ED7-41D3-BFFF-65C47E05C649Q28609040-5B9A8CFF-C8A3-4B83-B3BC-29B3AC8BF8D0Q28611445-B50DEE9D-8D71-4BD1-8568-E10FCAE8B624Q30452681-07024E52-BF45-4EDB-BBB3-DDE72937DCADQ33782337-AF7BC632-CC9F-466D-82BF-C515398280D1Q33804134-30B5D471-B4D1-4F73-949B-25944A895D2EQ33837688-EDDD7C2B-5351-496C-84C0-2651B0A93A6FQ38362429-6E376B32-9749-42BC-A1D0-8875D45CDF99Q40022357-ED9D6F9B-B4E5-44F7-9385-8E86883572CCQ40024215-7EA09BED-2E74-4E24-80F7-183D8B6772E8Q40314843-B805F358-BF6F-4F02-8EC7-10C0546547CFQ40884544-1D0E5489-7356-4F8A-856B-4B08EEFF973EQ41014122-B2C56489-360B-4A93-BB77-8D14D2C3EE9BQ41227606-322D92FB-B051-47C1-90B3-36AC280FAE56Q42809471-554D66C8-4931-40B7-BEF5-FE2C322FD7B2
P2860
v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
v-Abl-mediated apoptotic suppr ...... ted protein kinase activation.
@en
type
label
v-Abl-mediated apoptotic suppr ...... ted protein kinase activation.
@en
prefLabel
v-Abl-mediated apoptotic suppr ...... ted protein kinase activation.
@en
P2860
P356
P1476
v-Abl-mediated apoptotic suppr ...... ated protein kinase activation
@en
P2093
P2860
P304
P356
10.1074/JBC.270.11.5956
P407
P577
1995-03-01T00:00:00Z